MIM
RCEL icon

Monashee Investment Management’s Avita Medical RCEL Stock Holding History

Monashee Investment Management’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-74,229
Closed -$1.47M – 463
2021
Q1 		$1.47M Buy
+74,229
New +$1.73M 0.23% 134

Other funds holding RCEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BC
Blackcrane Capital Bellevue, Washington $16.3M AUM 19.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Monashee Investment Management's RCEL Position: Q2 2021 in Review

Monashee Investment Management sold out of Avita Medical (RCEL) in Q2 2021, closing a stake of 74,229 shares — an estimated $1.47M sold.

Monashee Investment Management first reported a position in RCEL in Q1 2021 and held it in 1 quarter. The position peaked at $1.47M in Q1 2021. 71 funds tracked by Wall St. Rank hold RCEL as of Q2 2021.

  • Monashee Investment Management reported no remaining Avita Medical position as of Q2 2021 after selling out during the quarter.
  • Monashee Investment Management sold 74,229 Avita Medical shares in Q2 2021, an estimated $1.47M.
  • Monashee Investment Management first reported a position in Avita Medical in Q1 2021 and held it in 1 quarter.
  • Monashee Investment Management's Avita Medical position peaked at $1.47M in Q1 2021.
  • 71 funds tracked by Wall St. Rank held Avita Medical as of Q2 2021.

Based on Monashee Investment Management's 13F filing for Q2 2021, filed 12 Aug 2021.